Results 91 to 100 of about 12,531 (249)

Restoration of cardiac function and prevention of multiorgan failure during the use of veno-arterial ECMO support and levosimendan therapy in a patient with refractory cardiogenic shock

, 2023
А А Еременко, М. А. Бабаев, V.V. Kolyvanova, T.P. Zyulyaeva, Dmitry Podolyak, E.P. Evseev, Ya. A. Aydamirov, T.A. Pshenichny, A.V. Urbanov, Р. Д. Комнов, R.S. Polyakov, A.S. Petrov   +11 more
openalex   +2 more sources

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. [PDF]

, 2017
OBJECTIVE: To provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012." DESIGN: A consensus committee of 55 international experts representing 25 international organizations was convened.
Alhazzani, W, Angus, DC, Annane, D, Antonelli, M, Beale, RJ, Bellinghan, GJ, Bernard, GR, Chiche, J-D, Coopersmith, C, De Backer, DP, Dellinger, RP, Evans, LE, Ferrer, R, French, CJ, Fujishima, S, Gerlach, H, Hidalgo, JL, Hollenberg, SM, Jones, AE, Karnad, DR, Kleinpell, RM, Koh, Y, Kumar, A, Levy, MM, Lisboa, TC, Machado, FR, Marini, JJ, Marshall, JC, Mazuski, JE, McIntyre, LA, McLean, AS, Mehta, S, Moreno, RP, Myburgh, J, Navalesi, P, Nishida, O, Nunnally, ME, Osborn, TM, Perner, A, Plunkett, CM, Ranieri, M, Rhodes, A, Rochwerg, B, Rubenfeld, GD, Schorr, CA, Seckel, MA, Sevransky, JE, Seymour, CW, Shieh, L, Shukri, KA, Simpson, SQ, Singer, M, Sprung, CL, Thompson, BT, Townsend, SR, Van der Poll, T, Vincent, J-L, Wiersinga, WJ, Zimmerman, JL   +58 more
core   +5 more sources

SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?

European Journal of Clinical Investigation, Volume 55, Issue 11, November 2025.
Flavio Tangianu, Eleonora Nicolini, Francesco Dentali, Aldo Bonaventura   +3 more
wiley   +1 more source

Dopamine is associated with the worst outcome among inotropes used in acute heart failure: observations from the ESC-HF-LT registry [PDF]

, 2017
Abstrac
Akiyama, Eiichi, Chioncel, Ovidiu, Crespo-Leiro, María Generosa, Filippatos, Gerasimos, Gayat, Etienne, Lund, Lars H., Maggioni, Aldo P., Mebazaa, Alexandre, Motiejunaite, J., Ruschitzka, Frank   +9 more
core   +2 more sources

The association between levosimendan and mortality in patients with sepsis or septic shock: a systematic review and meta-analysis

, 2023
Zengzheng Ge, Yanxia Gao, Xin Lu, Shiyuan Yu, Mubing Qin, Chao Gong, Joseph Harold Walline, Huadong Zhu, Yi Li   +8 more
openalex   +1 more source

Dataset related to the article "Why Levosimendan Improves the Clinical Condition of Patients With Advanced Heart Failure: A Holistic Approach"

, 2022
Anna Apostolo, Carlo Vignati, Michele Della Rocca, Fabiana De Martino, Giovanni Berna, Jeness Campodonico, Mauro Contini, Manuela Muratori, Pietro Palermo, Massimo Mapelli, Marina Alimento, Beatrice Pezzuto, Piergiuseppe Agostoni   +12 more
openalex   +1 more source

Old and new intravenous inotropic agents in the treatment of advanced heart failure [PDF]

, 2011
Inotropic agents are administered to improve cardiac output and peripheral perfusion in patients with systolic dysfunction and low cardiac output. However, there is evidence of increased mortality and adverse effects associated with current inotropic ...
Bettari L, Carubelli V, Dei Cas L., Metra M   +3 more
core   +1 more source

Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum [PDF]

, 2016
Catecholamines are endogenous neurosignalling mediators and hormones. They are integral in maintaining homeostasis by promptly responding to any stressor.
Andreis, DT, Singer, M
core   +1 more source

A simple prognostic index in acute heart failure [PDF]

, 2018
Background Rapid effective triage is integral to emergency care in patients hospitalized for heart failure, to guide the type and intensity of therapy.
Cristina MOLLICA, Lanfranco ANTONINI, Nadia ASPROMONTE, Vincenzo PASCERI   +3 more
core   +1 more source

eComment. Consider trying levosimendan [PDF]

Interactive CardioVascular and Thoracic Surgery, 2013
Levosimendan is a well established drug used nowadays routinely for the treatment of heart failure both in cardiology [1] as well as in cardiac surgery [2] despite the relatively high costs of administration [3] and the few, one must admit, adverse effects [4]. The review article by Angadi et al.
openaire   +2 more sources